Stereotaxis (NYSE:STXS) announced the publication of initial clinical results using its MAGiC robotic magnetic navigation catheter. The results, published in the Journal of Interventional Cardiac Electrophysiology, mark the first peer-reviewed literature supporting the efficacy and safety of MAGiC. MAGiC, a robotically navigated magnetic ablation … [Read more...] about Stereotaxis shares data supporting Magic catheter
Stereotaxis
Stereotaxis submits pair of catheters for FDA clearance
Stereotaxis today announced it submitted its EMAGIN 5F and MAGiC catheters for FDA clearance. EMAGIN 5F, short for Endovascular Magnetic Intervention, is a 5-French diameter that navigates tortuous venous and arterial vasculature. Stereotaxis designed it to enable efficient and safe navigation to access difficult-to-reach vascular … [Read more...] about Stereotaxis submits pair of catheters for FDA clearance
Stereotaxis Magic ablation catheter is now CE mark approved
Stereotaxis (NYSE:STXS) said today that it has secured CE mark approval for its Magic robotically-navigated magnetic ablation catheter. The St. Louis–based robotic surgery company submitted Magic for both CE mark and FDA approval nearly a year ago; it still awaits an FDA nod in the U.S. Magic performs cardiac ablation procedures to treat … [Read more...] about Stereotaxis Magic ablation catheter is now CE mark approved
Stereotaxis wins approval in China for magnetic ablation catheter
Stereotaxis (NYSE:STXS) announced today that its Magbot magnetic navigation ablation catheter received regulatory approval in China. This nod comes just weeks after the company won approval from China’s National Medical Products Administration for the Genesis robotic magnetic navigation (RNM) system. St. Louis, Missouri-based Stereotaxis aims to … [Read more...] about Stereotaxis wins approval in China for magnetic ablation catheter
Stereotaxis to acquire Access Point Technologies and its EP catheters
Stereotaxis (NYSE: STXS) is purchasing a Minneapolis-based electrophysiology (EP) catheter maker to further enhance its minimally invasive endovascular surgical robotics technology. St. Louis–based Stereotaxis did not disclose how much it is paying for Access Point Technologies in its after-hours news release. The transaction, paid with … [Read more...] about Stereotaxis to acquire Access Point Technologies and its EP catheters
The top catheter-based innovation news stories of 2024 — so far
Catheter innovations have had a remarkable year so far, with many receiving regulatory approval as they prepare to enter the market. The pulsed field ablation market heated up in 2023 and continues to make waves this year with more companies entering the space. Intravascular lithotripsy is having its moment as well – Shockwave Medical was … [Read more...] about The top catheter-based innovation news stories of 2024 — so far
Stereotaxis submits Magic ablation catheter for U.S., European approval
Stereotaxis (NYSE:STXS) announced that it submitted its Magic ablation catheter for both European and U.S. regulatory approval. The company said its FDA and CE mark submissions follow successful clinical results in an ongoing trial. Last month, Stereotaxis announced the first Magic treatments in the European trial supporting its submissions. … [Read more...] about Stereotaxis submits Magic ablation catheter for U.S., European approval
First patients treated using Stereotaxis MAGiC ablation catheter
Stereotaxis today announced the first patients have been successfully treated using its MAGiC magnetic interventional ablation catheter. The MAGiC catheter is a robotically navigated magnetic ablation catheter that performs minimally invasive cardiac ablation procedures. The first procedures were performed in Lithuania in eight patients … [Read more...] about First patients treated using Stereotaxis MAGiC ablation catheter
Stereotaxis submits robotically navigated ablation catheter for CE mark
Stereotaxis (NYSE:STXS) announced today that it submitted its MAGiC catheter for CE mark approval in Europe. The St. Louis-based company designed MAGiC as a robotically navigated, magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures. Used in conjunction with Stereotaxis' robotic systems, the catheter … [Read more...] about Stereotaxis submits robotically navigated ablation catheter for CE mark
Stereotaxis opens new headquarters in St. Louis
Surgical robotics company Stereotaxis (NYSE: STXS) is holding a grand opening today for its 45,000 ft² headquarters facility in downtown St. Louis. The new headquarters is located in the renovated historic Globe Building in St. Louis’s growing Downtown North Urban Insight District. It's an all-in-one facility housing research and development, … [Read more...] about Stereotaxis opens new headquarters in St. Louis
